Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis

Journal of Neurology

Volumn 262, Issue 4, 2015, Pages 814-822

  Chen, Yongdui ^a   Li, Siqi ^a   Su, Liling ^a   Sheng, Jinghao ^a   Lv, Wen ^b   Chen, Guangdi ^a   Xu, Zhengping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Meta analysis; Neurodegenerative disease; Polymorphism; Progranulin

Indexed keywords

GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; FRONTOTEMPORAL DEMENTIA; GENETICS; HUMAN; META ANALYSIS; PARKINSON DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84939955015     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7630-2     Document Type: Article

References (39)

1. Brown RC, Lockwood AH, Sonawane BR (2005) Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 113:1250–1256
2. Lill CM, Bertram L (2011) Towards unveiling the genetics of neurodegenerative diseases. Semin Neurol 31:531–541
3. Lagier-Tourenne C, Cleveland DW (2009) Rethinking ALS: the FUS about TDP-43. Cell 136:1001–1004
4. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D et al (2009) The heritability and genetics of frontotemporal lobar degeneration. Neurology 73:1451–1456
5. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916–919
6. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442:920–924
7. Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M et al (2007) Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry 78:754–756
8. Brouwers N, Nuytemans K, van der Zee J, Gijselinck I, Engelborghs S et al (2007) Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol 64:1436–1446
9. Ward ME, Miller BL (2011) Potential mechanisms of progranulin-deficient FTLD. J Mol Neurosci 45:574–582
10. Perry DC, Lehmann M, Yokoyama JS, Karydas A, Lee JJ et al (2013) Progranulin mutations as risk factors for Alzheimer disease. JAMA Neurol 70:774–778
11. Cannon A, Fujioka S, Rutherford NJ, Ferman TJ, Broderick DF et al (2013) Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis. Neurology 80:1771–1777
12. Rovelet-Lecrux A, Deramecourt V, Legallic S, Maurage CA, Le Ber I et al (2008) Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease. Neurobiol Dis 31:41–45
13. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M et al (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15:2988–3001
14. Cruts M, Van Broeckhoven C (2008) Loss of progranulin function in frontotemporal lobar degeneration. Trends Genet 24:186–194
15. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z et al (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17:3631–3642
16. Chang KH, Chen CM, Chen YC, Hsiao YC, Huang CC et al (2013) Association between GRN rs5848 polymorphism and Parkinson’s disease in Taiwanese population. PLoS One 8:e54448
17. Rollinson S, Rohrer JD, van der Zee J, Sleegers K, Mead S et al (2011) No association of PGRN 3′UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging 32:754–755
18. Fenoglio C, Galimberti D, Cortini F, Kauwe JS, Cruchaga C et al (2009) Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer’s disease. J Alzheimers Dis 18:603–612
19. Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M et al (2009) GRN 3′UTR+ 78 C>T is not associated with risk for Parkinson’s disease. Eur J Neurol 16:909–911
20. Del Bo R, Corti S, Santoro D, Ghione I, Fenoglio C et al (2011) No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort. Neurobiol Aging 32:1157–1158
21. Hayashino Y, Noguchi Y, Fukui T (2005) Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol 15:235–243
22. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
23. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B57:289–300
24. Lee MJ, Chen TF, Cheng TW, Chiu MJ (2011) rs5848 variant of progranulin gene is a risk of Alzheimer’s disease in the Taiwanese population. Neurodegener Dis 8:216–220
25. Galimberti D, Fenoglio C, Cortini F, Serpente M, Venturelli E et al (2010) GRN variability contributes to sporadic frontotemporal lobar degeneration. J Alzheimers Dis 19:171–177
26. Sleegers K, Brouwers N, Maurer-Stroh S, van Es MA, Van Damme P et al (2008) Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 71:253–259
27. Nuytemans K, Pals P, Sleegers K, Engelborghs S, Corsmit E et al (2008) Progranulin variability has no major role in Parkinson disease genetic etiology. Neurology 71:1147–1151
28. Kamalainen A, Viswanathan J, Natunen T, Helisalmi S, Kauppinen T et al (2013) GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer’s disease patients. J Alzheimers Dis 33:23–27
29. Viswanathan J, Makinen P, Helisalmi S, Haapasalo A, Soininen H et al (2009) An association study between granulin gene polymorphisms and Alzheimer’s disease in Finnish population. Am J Med Genet B Neuropsychiatr Genet 150B:747–750
30. Simon-Sanchez J, Seelaar H, Bochdanovits Z, Deeg DJ, van Swieten JC et al (2009) Variation at GRN 3′-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population. PLoS One 4:e7494
31. Xiao S, Sato C, Kawarai T, Goodall EF, Pall HS et al (2008) Genetic studies of GRN and IFT74 in amyotrophic lateral sclerosis. Neurobiol Aging 29:1279–1282
32. Brouwers N, Sleegers K, Engelborghs S, Maurer-Stroh S, Gijselinck I et al (2008) Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology 71:656–664
33. van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I et al (2007) Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat 28:416
34. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM et al (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55:964–968
35. Pereson S, Wils H, Kleinberger G, McGowan E, Vandewoestyne M et al (2009) Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. J Pathol 219:173–181
36. Dickson DW, Baker M, Rademakers R (2010) Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 7:170–174
37. He Z, Bateman A (2003) Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med (Berl) 81:600–612
38. Bateman A, Bennett HP (2009) The granulin gene family: from cancer to dementia. Bioessays 31:1245–1254
39. Gass J, Prudencio M, Stetler C, Petrucelli L (2012) Progranulin: an emerging target for FTLD therapies. Brain Res 1462:118–128